BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32179974)

  • 21. Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.
    Zheng M; Li Y; Li T; Zhang L; Zhou L
    Cancer Med; 2019 Sep; 8(11):5128-5136. PubMed ID: 31328428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study.
    Le Treut YP; Grégoire E; Klempnauer J; Belghiti J; Jouve E; Lerut J; Castaing D; Soubrane O; Boillot O; Mantion G; Homayounfar K; Bustamante M; Azoulay D; Wolf P; Krawczyk M; Pascher A; Suc B; Chiche L; de Urbina JO; Mejzlik V; Pascual M; Lodge JP; Gruttadauria S; Paye F; Pruvot FR; Thorban S; Foss A; Adam R;
    Ann Surg; 2013 May; 257(5):807-15. PubMed ID: 23532105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is Resection of Primary Midgut Neuroendocrine Tumors in Patients with Unresectable Metastatic Liver Disease Justified? A Systematic Review and Meta-Analysis.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Kostakis ID; Moris D; Schizas D; Cloyd JM; Pawlik TM
    J Gastrointest Surg; 2019 May; 23(5):1044-1054. PubMed ID: 30671800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postoperative morbidity and mortality after surgical resection of small bowel neuroendocrine neoplasms: A systematic review and meta-analysis.
    Kaçmaz E; Chen JW; Tanis PJ; Nieveen van Dijkum EJM; Engelsman AF
    J Neuroendocrinol; 2021 Aug; 33(8):e13008. PubMed ID: 34235792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms.
    Chakedis J; Beal EW; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha FG; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Marincola-Smith P; Cho C; Beems M; Pawlik TM; Maithel SK; Schmidt CR; Dillhoff M
    J Gastrointest Surg; 2019 Jan; 23(1):122-134. PubMed ID: 30334178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic surgery for metastases from neuroendocrine tumors.
    Sarmiento JM; Que FG
    Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resection versus transplantation for liver metastases from neuroendocrine tumors.
    Coppa J; Pulvirenti A; Schiavo M; Romito R; Collini P; Di Bartolomeo M; Fabbri A; Regalia E; Mazzaferro V
    Transplant Proc; 2001; 33(1-2):1537-9. PubMed ID: 11267413
    [No Abstract]   [Full Text] [Related]  

  • 28. Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival.
    Daskalakis K; Karakatsanis A; Hessman O; Stuart HC; Welin S; Tiensuu Janson E; Öberg K; Hellman P; Norlén O; Stålberg P
    JAMA Oncol; 2018 Feb; 4(2):183-189. PubMed ID: 29049611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?
    Chen H; Hardacre JM; Uzar A; Cameron JL; Choti MA
    J Am Coll Surg; 1998 Jul; 187(1):88-92; discussion 92-3. PubMed ID: 9660030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of Infectious Complications After Simultaneous Gastrointestinal and Liver Resections for Neuroendocrine Tumor Metastases.
    Acosta LF; Chacon E; Eman P; Dugan A; Davenport D; Gedaly R
    J Surg Res; 2019 Mar; 235():244-249. PubMed ID: 30691802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on Surgical Management of Small Bowel Neuroendocrine Tumors.
    Moris D; Ntanasis-Stathopoulos I; Tsilimigras DI; Vagios S; Karamitros A; Karaolanis G; Griniatsos J; Papalampros A; Papaconstantinou I; Glantzounis GK; Spartalis E; Blazer DG; Felekouras E
    Anticancer Res; 2018 Mar; 38(3):1267-1278. PubMed ID: 29491050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver resection for metastases not of colorectal, neuroendocrine, sarcomatous, or ovarian (NCNSO) origin: A multicentric study.
    Labgaa I; Slankamenac K; Schadde E; Jibara G; Alshebeeb K; Mentha G; Clavien PA; Schwartz M
    Am J Surg; 2018 Jan; 215(1):125-130. PubMed ID: 29061283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic micrometastases are associated with poor prognosis in patients with liver metastases from neuroendocrine tumors of the digestive tract.
    Gibson WE; Gonzalez RS; Cates JMM; Liu E; Shi C
    Hum Pathol; 2018 Sep; 79():109-115. PubMed ID: 29763717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical management of advanced pancreatic neuroendocrine tumors: short-term and long-term results from an international multi-institutional study.
    Birnbaum DJ; Turrini O; Vigano L; Russolillo N; Autret A; Moutardier V; Capussotti L; Le Treut YP; Delpero JR; Hardwigsen J
    Ann Surg Oncol; 2015 Mar; 22(3):1000-7. PubMed ID: 25190116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgery for small-bowel neuroendocrine tumors: is there any benefit of the laparoscopic approach?
    Figueiredo MN; Maggiori L; Gaujoux S; Couvelard A; Guedj N; Ruszniewski P; Panis Y
    Surg Endosc; 2014 May; 28(5):1720-6. PubMed ID: 24380996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A single institution's experience with surgical cytoreduction of stage IV, well-differentiated, small bowel neuroendocrine tumors.
    Boudreaux JP; Wang YZ; Diebold AE; Frey DJ; Anthony L; Uhlhorn AP; Ryan P; Woltering EA
    J Am Coll Surg; 2014 Apr; 218(4):837-44. PubMed ID: 24655881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effective cytoreduction can be achieved in patients with numerous neuroendocrine tumor liver metastases (NETLMs).
    Scott AT; Breheny PJ; Keck KJ; Bellizzi AM; Dillon JS; O'Dorisio TM; Howe JR
    Surgery; 2019 Jan; 165(1):166-175. PubMed ID: 30343949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study.
    Ahmed A; Turner G; King B; Jones L; Culliford D; McCance D; Ardill J; Johnston BT; Poston G; Rees M; Buxton-Thomas M; Caplin M; Ramage JK
    Endocr Relat Cancer; 2009 Sep; 16(3):885-94. PubMed ID: 19458024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. One stage curative resection of double intestinal neuroendocrine tumors with thirty-two bilobar liver metastases. A case report.
    Mirarchi M; De Raffele E; Cuicchi D; Lecce F; Cruciani G; Cola B
    Ann Ital Chir; 2015; 86(4):317-22. PubMed ID: 26344670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical Principles in the Management of Small Bowel Neuroendocrine Tumors.
    Gangi A; Anaya DA
    Curr Treat Options Oncol; 2020 Aug; 21(11):88. PubMed ID: 32862334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.